Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Maze Therapeutics, Inc. (MAZE) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-44.73M |
|
-- |
|
-- |
|
$48.03M |
|
$-48.03M |
|
$3.31M |
|
$-44.73M |
|
$-44.73M |
|
$-44.73M |
|
$-44.73M |
|
$-44.73M |
|
$-44.73M |
|
$-48.03M |
|
$-47.52M |
|
59.00M |
|
59.00M |
|
$-0.76 |
|
$-0.76 |
|
| Balance Sheet Financials | |
$420.42M |
|
$4.39M |
|
$111.20M |
|
$531.62M |
|
$22.96M |
|
$38.96M |
|
$55.54M |
|
$78.50M |
|
$453.12M |
|
$453.12M |
|
$453.12M |
|
55.51M |
|
| Cash Flow Statement Financials | |
$-54.17M |
|
$-122.23M |
|
$189.79M |
|
$190.34M |
|
$203.73M |
|
$13.40M |
|
$16.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.31 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
0.08 |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-54.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.87% |
|
-9.87% |
|
-8.41% |
|
-9.09% |
|
$8.16 |
|
$-0.92 |
|
$-0.92 |
|